Search results

Records found: 24  
Your query: Sysno = ("0184432" OR "0184391" OR "0184394" OR "0184448" OR "0184413" OR "0184378" OR "0184441" OR "0184437" OR "0184452" OR "0184400" OR "0184431" OR "0184392" OR "0184385" OR "0184374" OR "0184445" OR "0184420" OR "0184416" OR "0184434" OR "0184423" OR "0184387" OR "0184419" OR "0184403" OR "0184398" OR "0184410")

  1. 1.Abnormal expression and clinical significance of surface receptors on natural killer cells in the peripheral blood of patients with non-small cell lung cancer

    Abnormal expression and clinical significance of surface receptors on natural killer cells in the peripheral blood of patients with non-small cell lung cancer / Peng-Cheng Liu ... [et al.]. -- ilustr., obr., tab. -- Bibliogr. odkazy - Res. angl.

    In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2022. -- s. 747-993. -- ISSN 0028-2685. -- Vol. 69, no. 4 (2022), s. 931-939

    1. karcinóm pľúc, nemalobunkový 2. receptory prirodzených zabíjačských buniek - analýza - krv

    I. Liu, Peng-Cheng
    II. Neoplasma : journal of experimental and clinical oncology. -- Vol. 69, no. 4 (2022), s. 931-939

    expresia receptorov - vyhodnotenie súboru pacientov

  2. 2.Alleviation of neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma and its relationship with expression and changes of PD-L1

    Alleviation of neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma and its relationship with expression and changes of PD-L1 / Ye-Han Zhou ... [et al.]. -- ilustr., aj fareb., grafy, obr., tab. -- Bibliogr. odkazy - Res. angl.

    In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2022. -- s. 747-993. -- ISSN 0028-2685. -- Vol. 69, no. 4 (2022), s. 785-793

    1. karcinóm ezofageálnych skvamóznych buniek 2. terapia neoadjuvantná 3. antigén B7-H1 4. výsledok liečby

    I. Zhou, Ye-Han
    II. Neoplasma : journal of experimental and clinical oncology. -- Vol. 69, no. 4 (2022), s. 785-793

    chemorádioterapia neoadjuvantná - imunochemoterapia neoadjuvantná - expresia PD-L1 - odpoveď na liečbu - vyhodnotenie súboru pacientov retrospektívne

  3. 3.Anlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING/IFN-β pathway

    Anlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING/IFN-β pathway / Min Yuan ... [et al.]. -- ilustr., aj fareb., grafy, obr. -- Bibliogr. odkazy - Res. angl.

    In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2022. -- s. 747-993. -- ISSN 0028-2685. -- Vol. 69, no. 4 (2022), s. 807-819

    1. nádory žalúdka 2. proteíntyrozínkinázy - antagonisty a inhibítory 3. antigén B7-H1 4. procesy nádorové 5. línia bunková nádorová 6. testy protinádorového účinku na xenoimplantátových modeloch

    I. Yuan, Min
    II. Neoplasma : journal of experimental and clinical oncology. -- Vol. 69, no. 4 (2022), s. 807-819

    anlotinib - použitie terapeutické - expresia PD-L1 - štúdia experimentálna

  4. 4.Clinical outcomes of EGFR-TKIs in advanced squamous cell lung cancer

    Clinical outcomes of EGFR-TKIs in advanced squamous cell lung cancer / Jin-Fei Si ... [et al.]. -- Bibliogr. odkazy - Res. angl.

    In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2022. -- s. 747-993. -- ISSN 0028-2685. -- Vol. 69, no. 4 (2022), s. 976-982

    1. nádory pľúc 2. nádory zo skvamóznych buniek 3. receptory erbB - antagonisty a inhibítory 4. mutácia 5. prežívanie bez progresie 6. miera prežívania

    I. Si, Jin-Fei
    II. Neoplasma : journal of experimental and clinical oncology. -- Vol. 69, no. 4 (2022), s. 976-982

    inhibítory EGFR tyrozínkinázové - použitie terapeutické - mutácie EGFR - vyhodnotenie súboru pacientov

  5. 5.Cystathionine β-synthase expression correlates with tumor development and poor prognosis in lung squamous cell carcinoma patients

    Cystathionine β-synthase expression correlates with tumor development and poor prognosis in lung squamous cell carcinoma patients / Ya-Qing Han ... [et al.]. -- ilustr., aj fareb., grafy, obr., tab. -- Bibliogr. odkazy - Res. angl.

    In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2022. -- s. 747-993. -- ISSN 0028-2685. -- Vol. 69, no. 4 (2022), s. 868-876

    1. karcinóm pľúc, nemalobunkový 2. karcinóm skvamocelulárny 3. cystationín-beta-syntáza 4. prognóza

    I. Han, Ya-Qing
    II. Neoplasma : journal of experimental and clinical oncology. -- Vol. 69, no. 4 (2022), s. 868-876

    karcinóm pľúc skvamocelulárny - denzita mikrovaskulárna - expresia CBS - štúdia experimentálna

  6. 6.Endothelial lipase promotes acute myeloid leukemia progression through metabolic reprogramming

    Endothelial lipase promotes acute myeloid leukemia progression through metabolic reprogramming / Si-Qi Shang ... [et al.]. -- ilustr., aj fareb., grafy, obr. -- Bibliogr. odkazy - Res. angl.

    In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2022. -- s. 747-993. -- ISSN 0028-2685. -- Vol. 69, no. 4 (2022), s. 755-763

    1. leukémia myeloidná akútna 2. gény 3. lipáza 4. myši, kmene mutantné 5. techniky vloženia génu

    I. Shang, Si-Qi
    II. Neoplasma : journal of experimental and clinical oncology. -- Vol. 69, no. 4 (2022), s. 755-763

    myši knock-in - mutácia génu DNMT3A p.R878H - mutácia génu NRAS p.G12D - reprogramovan metabolické - lipáza endoteliálna LIPG - štúdia experimentálna

  7. 7.High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: Biopsy analysis of 70 cases from the Slovak Lymphoma Registry

    High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: Biopsy analysis of 70 cases from the Slovak Lymphoma Registry / Katarína Lešková ... [et al.]. -- ilustr., aj fareb., obr., tab. -- Bibliogr. odkazy - Res. angl.

    In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2022. -- s. 747-993. -- ISSN 0028-2685. -- Vol. 69, no. 4 (2022), s. 957-964

    1. lymfóm veľkobunkový difúzny, z B-buniek 2. biopsia 3. hybridizácia in situ, fluorescenčná

    I. Lešková, Katarína
    II. Szépe, Peter
    III. Balhárek, Tomáš
    IV. Barthová, Martina
    V. Janáková, Ľuboslava
    VI. Farkašová, Anna
    VII. Plank, Lukáš, 1951-
    VIII. Neoplasma : journal of experimental and clinical oncology. -- Vol. 69, no. 4 (2022), s. 957-964

    vyhodnotenie súboru pacientov retrospektívne

  8. 8.Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers

    Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers / Mihaela Ilcheva ... [et al.]. -- ilustr., aj fareb., graf, obr., tab. -- Bibliogr. odkazy - Res. angl.

    In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2022. -- s. 747-993. -- ISSN 0028-2685. -- Vol. 69, no. 4 (2022), s. 948-956

    1. nádory primárne mnohopočetné 2. tomografia pozitrónová emisná/tomografia počítačová 3. 18F fluórdeoxyglukóza 4. zobrazovanie diagnostické 5. výsledok liečby

    I. Ilcheva, Mihaela
    II. Neoplasma : journal of experimental and clinical oncology. -- Vol. 69, no. 4 (2022), s. 948-956

    18FDG PET/CT - vyhodnotenie súboru pacientov retrospektívne

  9. 9.Late effects of childhood cancer recorded at a single outpatient clinic over the course of one year: implications for follow-up care

    Late effects of childhood cancer recorded at a single outpatient clinic over the course of one year: implications for follow-up care / Tomas Kepak ... [et al.]. -- ilustr., obr., tab. -- Bibliogr. odkazy - Res. angl.

    In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2022. -- s. 747-993. -- ISSN 0028-2685. -- Vol. 69, no. 4 (2022), s. 983-992

    1. pacienti onkologickí preživajúci 2. stav zdravotný 3. komorbidita 4. dokumentácia zdravotná 5. prieskumy a dotazníky

    I. Kepák, Tomáš
    II. Neoplasma : journal of experimental and clinical oncology. -- Vol. 69, no. 4 (2022), s. 983-992

    vyhodnotenie súboru pacientov retrospektívne

  10. 10.LIMD2 promotes tumor proliferation, invasion, and epithelial-mesenchymal transition in clear cell renal cell carcinoma

    LIMD2 promotes tumor proliferation, invasion, and epithelial-mesenchymal transition in clear cell renal cell carcinoma / Qi-Yu Zhong ... [et al.]. -- ilustr., aj fareb., grafy, obr., tab. -- Bibliogr. odkazy - Res. angl.

    In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2022. -- s. 747-993. -- ISSN 0028-2685. -- Vol. 69, no. 4 (2022), s. 832-840

    1. karcinóm renálnych buniek 2. proteíny s doménou LIM 3. procesy nádorové 4. línia bunková nádorová 5. myši inbredné BALB C 6. testy protinádorového účinku na xenoimplantátových modeloch

    I. Zhong, Qi-Yu
    II. Neoplasma : journal of experimental and clinical oncology. -- Vol. 69, no. 4 (2022), s. 832-840

    expresia LIMD2 - štúdia experimentálna

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all